Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD

Roberto A. Rabinovich, Bruce E. Miller, Karolina Wrobel, Kareshma Ranjit, Michelle C. Williams, Ellen Drost, Lisa D. Edwards, David A. Lomas, Stephen I. Rennard, Alvar Agusti, Ruth Tal-Singer, Jorgen Vestbo, Emiel F. M. Wouters, Michelle John, Edwin J. R. van Beek, John T. Murchison, Charlotte E. Bolton, William MacNee, Jeffrey T. J. Huang

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)1365-1373
JournalEuropean Respiratory Journal
Volume47
Issue number5
DOIs
Publication statusPublished - May 2016

Cite this

Rabinovich, R. A., Miller, B. E., Wrobel, K., Ranjit, K., Williams, M. C., Drost, E., Edwards, L. D., Lomas, D. A., Rennard, S. I., Agusti, A., Tal-Singer, R., Vestbo, J., Wouters, E. F. M., John, M., van Beek, E. J. R., Murchison, J. T., Bolton, C. E., MacNee, W., & Huang, J. T. J. (2016). Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD. European Respiratory Journal, 47(5), 1365-1373. https://doi.org/10.1183/13993003.01824-2015